[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Next-Generation Biologics Market Report 2016

November 2016 | 104 pages | ID: E4023B62E0FEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Next-Generation Biologics

Revenue, means the sales value of Next-Generation Biologics

This report studies sales (consumption) of Next-Generation Biologics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Allergan
  • Bayer
  • Biogen Idec
  • Eli Lilly
  • Kyowa Hakko Kirin
  • Molecular Partners
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Next-Generation Biologics in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Antibodies
  • Regenerative medicine
  • Insulins
  • Growth hormones
  • Other
Split by application, this report focuses on sales, market share and growth rate of Next-Generation Biologics in each application, can be divided into
  • Medical
  • Scientific Research
  • Other
Europe Next-Generation Biologics Market Report 2016

1 NEXT-GENERATION BIOLOGICS OVERVIEW

1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics
  1.2.1 Antibodies
  1.2.2 Regenerative medicine
  1.2.3 Insulins
  1.2.4 Growth hormones
  1.2.5 Other
1.3 Application of Next-Generation Biologics
  1.3.1 Medical
  1.3.2 Scientific Research
  1.3.3 Other
1.4 Next-Generation Biologics Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Next-Generation Biologics (2011-2021)
  1.5.1 Europe Next-Generation Biologics Sales and Growth Rate (2011-2021)
  1.5.2 Europe Next-Generation Biologics Revenue and Growth Rate (2011-2021)

2 EUROPE NEXT-GENERATION BIOLOGICS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Next-Generation Biologics Market Competition by Manufacturers
  2.1.1 Europe Next-Generation Biologics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Next-Generation Biologics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Next-Generation Biologics (Volume and Value) by Type
  2.2.1 Europe Next-Generation Biologics Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
2.3 Europe Next-Generation Biologics (Volume and Value) by Countries
  2.3.1 Europe Next-Generation Biologics Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Next-Generation Biologics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Next-Generation Biologics (Volume) by Application

3 GERMANY NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Next-Generation Biologics Sales and Value (2011-2016)
  3.1.1 Germany Next-Generation Biologics Sales and Growth Rate (2011-2016)
  3.1.2 Germany Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Next-Generation Biologics Sales Price Trend (2011-2016)
3.2 Germany Next-Generation Biologics Sales and Market Share by Manufacturers
3.3 Germany Next-Generation Biologics Sales and Market Share by Type
3.4 Germany Next-Generation Biologics Sales and Market Share by Application

4 FRANCE NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

4.1 France Next-Generation Biologics Sales and Value (2011-2016)
  4.1.1 France Next-Generation Biologics Sales and Growth Rate (2011-2016)
  4.1.2 France Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  4.1.4 France Next-Generation Biologics Sales Price Trend (2011-2016)
4.2 France Next-Generation Biologics Sales and Market Share by Manufacturers
4.3 France Next-Generation Biologics Sales and Market Share by Type
4.4 France Next-Generation Biologics Sales and Market Share by Application

5 UK NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Next-Generation Biologics Sales and Value (2011-2016)
  5.1.1 UK Next-Generation Biologics Sales and Growth Rate (2011-2016)
  5.1.2 UK Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  5.1.5 UK Next-Generation Biologics Sales Price Trend (2011-2016)
5.2 UK Next-Generation Biologics Sales and Market Share by Manufacturers
5.3 UK Next-Generation Biologics Sales and Market Share by Type
5.4 UK Next-Generation Biologics Sales and Market Share by Application

6 RUSSIA NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Next-Generation Biologics Sales and Value (2011-2016)
  6.1.1 Russia Next-Generation Biologics Sales and Growth Rate (2011-2016)
  6.1.2 Russia Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Next-Generation Biologics Sales Price Trend (2011-2016)
6.2 Russia Next-Generation Biologics Sales and Market Share by Manufacturers
6.3 Russia Next-Generation Biologics Sales and Market Share by Type
6.4 Russia Next-Generation Biologics Sales and Market Share by Application

7 ITALY NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Next-Generation Biologics Sales and Value (2011-2016)
  7.1.1 Italy Next-Generation Biologics Sales and Growth Rate (2011-2016)
  7.1.2 Italy Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Next-Generation Biologics Sales Price Trend (2011-2016)
7.2 Italy Next-Generation Biologics Sales and Market Share by Manufacturers
7.3 Italy Next-Generation Biologics Sales and Market Share by Type
7.4 Italy Next-Generation Biologics Sales and Market Share by Application

8 SPAIN NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Next-Generation Biologics Sales and Value (2011-2016)
  8.1.1 Spain Next-Generation Biologics Sales and Growth Rate (2011-2016)
  8.1.2 Spain Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Next-Generation Biologics Sales Price Trend (2011-2016)
8.2 Spain Next-Generation Biologics Sales and Market Share by Manufacturers
8.3 Spain Next-Generation Biologics Sales and Market Share by Type
8.4 Spain Next-Generation Biologics Sales and Market Share by Application

9 BENELUX NEXT-GENERATION BIOLOGICS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Next-Generation Biologics Sales and Value (2011-2016)
  9.1.1 Benelux Next-Generation Biologics Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Next-Generation Biologics Sales Price Trend (2011-2016)
9.2 Benelux Next-Generation Biologics Sales and Market Share by Manufacturers
9.3 Benelux Next-Generation Biologics Sales and Market Share by Type
9.4 Benelux Next-Generation Biologics Sales and Market Share by Application

10 EUROPE NEXT-GENERATION BIOLOGICS MANUFACTURERS ANALYSIS

10.1 Allergan
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Next-Generation Biologics Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Bayer
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Next-Generation Biologics Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Biogen Idec
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Next-Generation Biologics Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Eli Lilly
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Next-Generation Biologics Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Kyowa Hakko Kirin
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Next-Generation Biologics Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Molecular Partners
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Next-Generation Biologics Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Next-Generation Biologics Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Pfizer
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Next-Generation Biologics Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Roche
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Next-Generation Biologics Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Sanofi
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Next-Generation Biologics Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 NEXT-GENERATION BIOLOGICS MANUFACTURING COST ANALYSIS

11.1 Next-Generation Biologics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Next-Generation Biologics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Next-Generation Biologics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE NEXT-GENERATION BIOLOGICS MARKET FORECAST (2016-2021)

14.1 Germany Next-Generation Biologics Sales Forecast (2016-2021)
14.2 France Next-Generation Biologics Sales Forecast (2016-2021)
14.3 UK Next-Generation Biologics Sales Forecast (2016-2021)
14.4 Russia Next-Generation Biologics Sales Forecast (2016-2021)
14.5 Italy Next-Generation Biologics Sales Forecast (2016-2021)
14.6 Spain Next-Generation Biologics Sales Forecast (2016-2021)
14.7 Benelux Next-Generation Biologics Sales Forecast (2016-2021)
14.8 Europe Next-Generation Biologics Sales Forecast by Type (2016-2021)
14.9 Europe Next-Generation Biologics Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
LIST OF TABLES AND FIGURES

Figure Picture of Next-Generation Biologics
Table Classification of Next-Generation Biologics
Figure Europe Sales Market Share of Next-Generation Biologics by Type in 2015
Figure Antibodies Picture
Figure Regenerative medicine Picture
Figure Insulins Picture
Figure Growth hormones Picture
Figure Other Picture
Table Application of Next-Generation Biologics
Figure Europe Sales Market Share of Next-Generation Biologics by Application in 2015
Figure Medical Examples
Figure Scientific Research Examples
Figure Other Examples
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure France Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Spain Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Sales and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Table Europe Next-Generation Biologics Sales of Key Manufacturers (2015 and 2016)
Table Europe Next-Generation Biologics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Next-Generation Biologics Sales Share by Manufacturers
Figure 2016 Next-Generation Biologics Sales Share by Manufacturers
Table Europe Next-Generation Biologics Revenue by Manufacturers (2015 and 2016)
Table Europe Next-Generation Biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Next-Generation Biologics Revenue Share by Manufacturers
Table 2016 Europe Next-Generation Biologics Revenue Share by Manufacturers
Table Europe Next-Generation Biologics Sales and Market Share by Type (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Type (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Type (2011-2016)
Figure Europe Next-Generation Biologics Sales Growth Rate by Type (2011-2016)
Table Europe Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
Table Europe Next-Generation Biologics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Type (2011-2016)
Figure Europe Next-Generation Biologics Revenue Growth Rate by Type (2011-2016)
Table Europe Next-Generation Biologics Sales and Market Share by Countries (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Countries (2011-2016)
Table Europe Next-Generation Biologics Revenue and Market Share by Countries (2011-2016)
Table Europe Next-Generation Biologics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Countries (2011-2016)
Table Europe Next-Generation Biologics Sales and Market Share by Application (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Application (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Application (2011-2016)
Figure Germany Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Germany Next-Generation Biologics Sales Price Trend (2011-2016)
Table Germany Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Germany Next-Generation Biologics Sales by Type (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Germany Next-Generation Biologics Sales by Application (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure France Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure France Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure France Next-Generation Biologics Sales Price Trend (2011-2016)
Table France Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table France Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table France Next-Generation Biologics Sales by Type (2015 and 2016)
Table France Next-Generation Biologics Market Share by Type (2015 and 2016)
Table France Next-Generation Biologics Sales by Application (2015 and 2016)
Table France Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure UK Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure UK Next-Generation Biologics Sales Price Trend (2011-2016)
Table UK Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table UK Next-Generation Biologics Sales by Type (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Type (2015 and 2016)
Table UK Next-Generation Biologics Sales by Application (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Russia Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Russia Next-Generation Biologics Sales Price Trend (2011-2016)
Table Russia Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Russia Next-Generation Biologics Sales by Type (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Russia Next-Generation Biologics Sales by Application (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Italy Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Italy Next-Generation Biologics Sales Price Trend (2011-2016)
Table Italy Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Italy Next-Generation Biologics Sales by Type (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Italy Next-Generation Biologics Sales by Application (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Spain Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Spain Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Spain Next-Generation Biologics Sales Price Trend (2011-2016)
Table Spain Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Spain Next-Generation Biologics Sales by Type (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Spain Next-Generation Biologics Sales by Application (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Benelux Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Benelux Next-Generation Biologics Sales Price Trend (2011-2016)
Table Benelux Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Benelux Next-Generation Biologics Sales by Type (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Benelux Next-Generation Biologics Sales by Application (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Application (2015 and 2016)
Table Next-Generation Biologics Basic Information List
Table Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Next-Generation Biologics Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Next-Generation Biologics Sales Market Share (2011-2016)
Table Biogen Idec Basic Information List
Table Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Idec Next-Generation Biologics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Next-Generation Biologics Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Next-Generation Biologics Sales Market Share (2011-2016)
Table Molecular Partners Basic Information List
Table Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Molecular Partners Next-Generation Biologics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Next-Generation Biologics Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Next-Generation Biologics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Next-Generation Biologics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Next-Generation Biologics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next-Generation Biologics
Figure Manufacturing Process Analysis of Next-Generation Biologics
Figure Next-Generation Biologics Industrial Chain Analysis
Table Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
Table Major Buyers of Next-Generation Biologics
Table Distributors/Traders List
Figure Germany Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure France Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure France Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure UK Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Next-Generation Biologics Sales Forecast by Type (2016-2021)
Table Europe Next-Generation Biologics Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories